Sponsored by:

Nuclear Medicine: Page 401

PET, SPECT given equal weight at SNM 2002
By Shalmali Pal
Once an also-ran to other technologies, PET is finally coming into its own within the diagnostic armamentarium of the nuclear medicine physician. One sign of PET’s arrival was the fact that PET and SPECT results tied for Image of the Year at the 2002 Society of Nuclear Medicine meeting, June 18-21, in Los Angeles.
September 5, 2002
Peregrine begins Nasdaq grace period
By AuntMinnie.com staff writers
Biopharmaceutical firm Peregrine Pharmaceuticals has been notified by Nasdaq that its common stock has failed to maintain a minimum bid price of $1.00 over the last 30 consecutive trading days.
August 21, 2002
Center for Molecular Imaging set to launch
By AuntMinnie.com staff writers
The University of Michigan Health System (UMHS) and the Van Andel Research Institute (VARI) in Grand Rapids, MI, are creating a new facility for cancer imaging.
August 20, 2002
NAS ups sales, trims losses in Q3
By AuntMinnie.com staff writers
Radiopharmaceutical developer North American Scientific reported third-quarter net sales of $5.3 million, up 9% from the $4.9 million reported in the third quarter of 2001.
August 19, 2002
Positron revenues jump, losses continue
By AuntMinnie.com staff writers
PET manufacturer Positron reported second-quarter revenues of $2.4 million, more than five times the $449,000 reported in the second quarter of 2001.
August 18, 2002
Dobutamine SPECT helps assess myocardial viability
Stress-gated SPECT imaging with a dobutamine-based radiopharmaceutical shows promise as a cardiac stress test, according to researchers from the Medical School of Ribeirao Preto in Brazil and the Hokkaido University Graduate School of Medicine in Japan.
August 18, 2002
Cytogen warned by Nasdaq
By AuntMinnie.com staff writers
Pharmaceutical firm Cytogen has been notified by the Nasdaq Stock Market that for more than 30 consecutive trading days, its common stock has closed below the minimum $1 per share required for continued listing on the Nasdaq National Market.
August 14, 2002
Peregrine closes institutional investment deal
By AuntMinnie.com staff writers
Biopharmaceutical firm Peregrine Pharmaceuticals has closed an offering for $2.9 million shares of its common stock in exchange for $1.8 million from an institutional investor.
August 13, 2002
CDI launches PET service
By AuntMinnie.com staff writers
Imaging services provider Center for Diagnostic Imaging has opened a PET scanning program at its St. Louis Park Center location in Minnesota.
August 12, 2002
SN localization proves worthwhile in multifocal invasive breast carcinoma
Researchers from St. Vincent’s Hospital and Medical Center in New York City and the Hospital of the University of Pennsylvania in Philadelphia have reported new applications for sentinel node localization in breast cancer patients.
August 11, 2002
CTI revenues climb 81%
By AuntMinnie.com staff writers
PET provider CTI Molecular Imaging reported fiscal third-quarter revenues of $69 million, up 81% compared with the $38.1 million posted in the same period last year.
August 7, 2002
CTI, DVI form financing alliance
By AuntMinnie.com staff writers
PET developer CTI Molecular Imaging has entered into a partnership with healthcare financing firm DVI.
August 5, 2002
Previous Page
Page 401 of 439
Next Page